Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
18.48
0.00 (0.00%)
Aug 18, 2026, 9:30 AM EDT - Market open
Trevi Therapeutics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Trevi Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $28.18. The average 1-year stock price forecast is 52.49% higher than the current stock price, while the lowest is $23 (+24.46%) and the highest is $40 (+116.45%).
Price Target: $28.18 (+52.49%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Trevi Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $24 → $28 | Buy | Reiterates | $24 → $28 | +51.52% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $24 | Buy | Maintains | $24 | +29.87% | Aug 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $23 | Buy | Reiterates | $23 | +24.46% | Aug 10, 2026 |
| Needham | Needham | Buy Maintains $23 | Buy | Maintains | $23 | +24.46% | Aug 7, 2026 |
| Raymond James | Raymond James | Buy Maintains $40 | Buy | Maintains | $40 | +116.45% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.48
from -0.32
EPS Next Year
-0.58
from -0.48
EPS and Forward PE are based on non-GAAP adjusted numbers.